Resolving tumor microenvironment heterogeneity to forecast immunotherapy response in triple-negative breast cancer through multi-scale analysis
BackgroundImmunotherapy has been used in the clinical management of TNBC. While BRCA1 mutations are associated with immunotherapy response, the therapeutic outcomes in TNBC patients are not promising.MethodsThis study integrated spatial, single-cell, and bulk RNA-seq data to explore the role of BRCA...
Saved in:
| Main Authors: | Shihao Sun, Shuang Chen, Kaiyuan Li, Ge Zhang, Nan Wang, Yijia Xu, Xinxing Wang, Jiangrui Chi, Lin Li, Yi Sun |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-08-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1538574/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A multifunctional biomimetic nanoplatform combined with immune checkpoint blockade for triple-negative breast cancer immunotherapy through inhibiting polarization of M2 macrophages
by: Qianqian Zhou, et al.
Published: (2025-08-01) -
Multiple drug resistance caused by germline mutation of exon 27 of BRCA2 gene in triple-negative breast cancer: a case report and literature review
by: Yuting Li, et al.
Published: (2025-06-01) -
The relationship between mutation carriage of BRCA1/2 and clinicopathological characteristics in women with breast cancer – experience from a diagnostic centre in Turkey
by: Neslihan Duzkale, et al.
Published: (2024-09-01) -
Molecular subtyping and target identification in triple negative breast cancer through immunohistochemistry biomarkers
by: Rima Saad Bouzid, et al.
Published: (2025-03-01) -
Immunotherapy for triple-negative breast cancer: current trends and future prospects
by: Amina Essalihi, et al.
Published: (2025-06-01)